respiratory
Asthma

Patients need to know potential risks of montelukast


Neuropsychiatric symptoms such as aggression, suicidal ideation, abnormal behaviour and nightmares are amongst the most common adverse drug reactions reported in children and adults taking montelukast (Singulair) for their asthma. A study of both Dutch and WHO Global pharmacovigilance databases found odds ratios as high as 24.99 for aggression, 20.43 for suicidal ideation, 34.05 for ...

Already a member?

Enter your email to keep reading.


OR